Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urinary Bladder Neoplasms × Enoxaparin × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 9 Venous Thromboembolism 7 Venous Thrombosis 6 Pulmonary Embolism 4 Pancreatic Neoplasms 4 Thrombosis 3 Thromboembolism 3 Lymphoma 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Ovarian Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Carcinoma, Non-Small-Cell Lung 2 Venous Thormboembolism 1 Urinary Bladder Neoplasms 1 Thrombocytopenia 1 Stroke 1 Stomach Neoplasms 1 Soft Tissue Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1

Interventions

Gemcitabine 74 Cisplatin 57 Cystectomy 36 pembrolizumab 30 Docetaxel 24 durvalumab 21 Nivolumab 20 Paclitaxel 17 Radiotherapy 16 Magnetic Resonance Spectroscopy 15 Mitomycin 14 Carboplatin 13 Doxorubicin 12 Cystoscopy 12 atezolizumab 11 Standard of Care 11 BCG Vaccine 11 avelumab 10 tremelimumab 9 Surveys and Questionnaires 9 Sunitinib 9 Specimen Handling 8 Ipilimumab 8 Filgrastim 8 Blood Specimen Collection 8 Transurethral Resection of Bladder 7 Neoadjuvant Therapy 7 Methotrexate 7 Methods 7 Early Intervention, Educational 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06243510 2026-01-28

CARE

Abramson Cancer Center at Penn Medicine

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡